Navigation Links
Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

cer. A second drug development candidate, TELINTRA(TM) (TLK199), is in clinical development for myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.

This press release contains "forward-looking" statements, including statements regarding the potential for TELCYTA to treat one or more types of cancer. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, that none of Telik's product candidates have been determined to be safe or effective in humans or been approved for marketing, clinical trials of Telik's product candidates may take several years to complete and may not be successful, success in preclinical testing and early clinical trials does not ensure that later clinical trials will be successful and interim results of clinical trials do not necessarily predict final results. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its annual report on Form 10-K for the year ended December 31, 2006. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELCYTA, TELINTRA and TRAP are trademarks or registered trademarks of Telik, Inc.

CONTACT: Carol D. DeGuzman, Senior Director, Corporate Communications ofTelik, Inc. +1-650-845-7728, cdeguzman@telik.com

Web site: '"/>




Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive ... regulatory and marketplace changes. CI leaders who adjust will ... In a new Best Practices, LLC study CI ... actionable insights, including: - Use secondary research ... primary research - Internal staff who are ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston ... multinational study on stent removability and preliminary long ... been published in the August issue of the ... study 1 is being conducted in 11 ... fully covered self-expanding metal stents (FCSEMS) after extended ...
(Date:8/29/2014)... Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... Global Healthcare Conference on Wednesday, September 10. ... Officer, will provide an update on the company, beginning ... Daylight Time).   A webcast of the ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... March 26, 2012   Sigma-Aldrich ® Corporation (Nasdaq: ... of Europe,s Top Employers by the Corporate Research ... business journalists, trade associations, researchers and international publishers ... acknowledgement.  Sigma-Aldrich is one of nine companies that ...
... -- Pennystocksinsiders.com (PSI) has issued insider trading reports and ... Atmel (NASDAQ: ATML), USG (NYSE: USG), Applied Materials (NASDAQ: ... and Key Energy Services (NYSE: KEG). ... report by clicking the link below, you may need ...
Cached Medicine Technology:CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 2CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 3Equity Research on Most Popular Searches: Atmel, USG, Applied Materials, Sprint Nextel, Galena Biopharma, and Key Energy Services 2Equity Research on Most Popular Searches: Atmel, USG, Applied Materials, Sprint Nextel, Galena Biopharma, and Key Energy Services 3
(Date:8/31/2014)... (PRWEB) August 31, 2014 Priya ... NutriGold , expressed concern over misinformation about weight-loss ... conflicting and, quite often, misleading information being propagated ... TV personalities are weighing in on the ... about vitamins, supplements, and especially weight-loss products and ...
(Date:8/31/2014)... Healthy Grid announced the impending release ... lollipops will use herbs to fight the bacteria that cause ... fight bacteria while stimulating saliva production. , “We're very excited ... of Healthy Grid. “Even though personal dental care is on ... little more prevention. Cavities are painful and expensive but these ...
(Date:8/31/2014)... Brook Forest Voices , audiobook producer and ... Short Stories of Wisdom and Kindness from Around the ... Jackson author, speaker, humanitarian and cultural economist. , In ... vast volume of meticulously handwritten notes taken while traveling ... behalf of Project C.U.R.E . Founded in 1987 ...
(Date:8/31/2014)... denervation seems to be more successful at reducing blood ... accessory renal arteries, according to research presented at ESC ... Dr Schmiedel said: "More than one billion people worldwide ... pressure (BP) greater than 140/90 mmHg. Up to 15% ... unable to reduce BP below 140/90 mmHg despite adhering ...
(Date:8/30/2014)... Local anaesthetic is as safe and effective for transcatheter ... results of the FRANCE 2 registry presented at ESC ... Dr Chopard said: "Numerous studies have shown that TAVI ... symptomatic aortic stenosis who are at very high risk ... number of TAVI procedures in France and around the ...
Breaking Medicine News(10 mins):Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Healthy Grid: Fight Cavities With Sweet Treats 2Health News:Healthy Grid: Fight Cavities With Sweet Treats 3Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Renal denervation more successful when it includes accessory arteries 2Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2
... 3 (HealthDay News) -- The impending extinction of various ... important buffer against the transmission of infectious disease, new ... U.S. National Science Foundation and National Institutes of Health,s ... Environmental Protection Agency, focused on how the loss of ...
... findings will be highly useful to the manufacturing industry ... toothpaste, cosmetics, pharmaceuticals and foodstuffs depends on an understanding ... The research just published in Nature ... of Physics and Astronomy, with collaborators at the University ...
... Nearly a quarter of Americans live in rural areas, which ... and suburban areas. Among the complex causes for this disparity ... areas and almost 4 out of 10 rural residents ... Finding the time, transportation, and financial resources for travel ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... can cut your risk for first-time stroke by 80 ... Association and the American Stroke Association. Also, as ... care, ER doctors are in a position to identify ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Dec. ... Department of Health and Human Services (HHS) has announced its ... including making dents in rates of obesity, smoking and deaths ... People is to try to move the nation to better ...
... From hotel-style room service to massage therapy to magnificent ... a bid to gain market share, especially those in ... in the New England Journal of Medicine , ... hospital care, explaining that how we decide to value ...
Cached Medicine News:Health News:Species Extinctions May Spell Trouble for Human Health 2Health News:Smashing fluids: The physics of flow 2Health News:ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA 2Health News:Lifestyle Key to Preventing Stroke, Guidelines Say 2Health News:U.S. Government Sets New Health Goals for 2020 2Health News:U.S. Government Sets New Health Goals for 2020 3Health News:Hospital perks: How much should hospitals be rewarded for the patient experience? 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: